Mechanistic studies of MALAT1 in respiratory diseases
- PMID: 36419933
- PMCID: PMC9676952
- DOI: 10.3389/fmolb.2022.1031861
Mechanistic studies of MALAT1 in respiratory diseases
Abstract
Background: The incidence of respiratory diseases and the respiratory disease mortality rate have increased in recent years. Recent studies have shown that long non-coding RNA (lncRNA) MALAT1 is involved in various respiratory diseases. In vascular endothelial and cancer cells, MALAT1 expression triggers various changes such as proinflammatory cytokine expression, cancer cell proliferation and metastasis, and increased endothelial cell permeability. Methods: In this review, we performed a relative concentration index (RCI) analysis of the lncRNA database to assess differences in MALAT1 expression in different cell lines and at different locations in the same cell, and summarize the molecular mechanisms of MALAT1 in the pathophysiology of respiratory diseases and its potential therapeutic application in these conditions. Results: MALAT1 plays an important regulatory role in lncRNA with a wide range of effects in respiratory diseases. The available evidence shows that MALAT1 plays an important role in the regulation of multiple respiratory diseases. Conclusion: MALAT1 is an important regulatory biomarker for respiratory disease. Targeting the regulation MALAT1 could have important applications for the future treatment of respiratory diseases.
Keywords: long-stranded non-coding RNA; lung cancer; metastasis-associated lung adenocarcinoma transcript; respiratory disease; severe acute respiratory syndrome coronavirus.
Copyright © 2022 Wu, Wang, Zhang, Mao, Wang, Wang, Zhao, Zhao, Mou and Yan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
MALAT1: a potential biomarker in cancer.Cancer Manag Res. 2018 Dec 6;10:6757-6768. doi: 10.2147/CMAR.S169406. eCollection 2018. Cancer Manag Res. 2018. PMID: 30584369 Free PMC article. Review.
-
Long non-coding RNA MALAT1 interaction with miR-429 regulates the proliferation and EMT of lung adenocarcinoma cells through RhoA.Int J Clin Exp Pathol. 2019 Feb 1;12(2):419-430. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933847 Free PMC article.
-
MALAT1: A long non-coding RNA highly associated with human cancers.Oncol Lett. 2018 Jul;16(1):19-26. doi: 10.3892/ol.2018.8613. Epub 2018 May 2. Oncol Lett. 2018. PMID: 29928382 Free PMC article. Review.
-
Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.Mol Hum Reprod. 2019 Jan 1;25(1):17-29. doi: 10.1093/molehr/gay045. Mol Hum Reprod. 2019. PMID: 30371869
-
Long Non-coding RNA MALAT1: A Key Player in Liver Diseases.Front Med (Lausanne). 2022 Jan 25;8:734643. doi: 10.3389/fmed.2021.734643. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35145971 Free PMC article. Review.
Cited by
-
LncRNA MALAT1 serves as a risk factor in perioperative respiratory adverse events in children under general anesthesia.Toxicol Res (Camb). 2025 May 13;14(3):tfaf068. doi: 10.1093/toxres/tfaf068. eCollection 2025 Jun. Toxicol Res (Camb). 2025. PMID: 40370486
-
Emerging role of long non-coding RNA MALAT1 related signaling pathways in the pathogenesis of lung disease.Front Cell Dev Biol. 2023 May 11;11:1149499. doi: 10.3389/fcell.2023.1149499. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37250901 Free PMC article. Review.
-
Long Noncoding RNA: A Novel Insight into the Pathogenesis of Acute Lung Injury.J Clin Med. 2023 Jan 11;12(2):604. doi: 10.3390/jcm12020604. J Clin Med. 2023. PMID: 36675533 Free PMC article. Review.
-
The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.J Transl Med. 2023 Oct 9;21(1):706. doi: 10.1186/s12967-023-04584-8. J Transl Med. 2023. PMID: 37814337 Free PMC article. Review.
-
LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer.Molecules. 2023 Feb 24;28(5):2126. doi: 10.3390/molecules28052126. Molecules. 2023. PMID: 36903369 Free PMC article. Review.
References
-
- Bertram S., Heurich A., Lavender H., Gierer S., Danisch S., Perin P., et al. (2012). Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One 7 (4), e35876. 10.1371/journal.pone.0035876 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources